Stocks making the biggest moves midday: Nvidia, Lennar, Adobe and more

Business

In this article

A sign is posted in front of the NVIDIA headquarters on May 10, 2018 in Santa Clara, California.
Justin Sullivan/Getty Images

Check out the companies making headlines in midday trading.

Nvidia — Shares of Nvidia gained 2.3% after Bank of America raised its price target on the stock to $900 per share from $800 per share. The bank said “rising AI adoption, expanding use-cases across cloud, enterprise, edge, telco can help NVDA double its content and triple its data center sales over the next few years.”

Lennar — Lennar shares added 5.2% after JPMorgan upgraded the homebuilder to overweight from neutral. JPMorgan said Lennar’s stock as “attractive relative to its peers and effectively not reflecting the company’s significant and ongoing business transformation.”

Adobe — Shares of the digital cloud giant traded nearly 2% higher on the back of better-than-expected quarterly numbers. Adobe reported earnings per share of $3.03 on revenue of $3.84 billion. Analysts expected a profit of $2.81 per share on sales of $3.73 billion, according to Refinitiv.

Smith & Wesson Brands — The firearms manufacturer stock surged 15% after the company quarterly results that beat analyst expectations. Smith & Wesson’s earnings per share of $1.71 beat a Refinitiv forecast by 69 cents. The company’s revenue of $322.9 million also surpassed an estimate of $259.8 million. Smith & Wesson also raised its dividend by 60% and authorized a $50 million stock buyback.

Orphazyme — Shares of Orphazyme plunged 42% after U.S. regulators rejected its application for a drug intended to treat Niemann-Pick disease type C.

Fox Corporation — Fox shares gained 2% after the company upped its stock repurchase program by $2 billion to a total of $4 billion.

Citigroup — The bank stock fell 1.6% midday, putting it on pace for its 12th straight daily loss. Shares of Citigroup are down more than 11% this week.

— CNBC’s Tanaya Macheel contributed reporting

Become a smarter investor with CNBC Pro
Get stock picks, analyst calls, exclusive interviews and access to CNBC TV. 
Sign up to start a free trial today

Products You May Like

Articles You May Like

Movie Review: ‘Sonic the Hedgehog 3’
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
Behind the Film’s Opening Shot
Charlie’s Angels: The Show That Empowered Women and Changed TV Forever
Starbucks workers strike in LA, Chicago and Seattle ahead of Christmas